Lifecore Biomedical, Inc.
LFCR • NASDAQ
Lifecore Biomedical, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Paul Josephs, with a market cap of $176.9M.
Market Cap$176.9M
Employees459.0
CEOPaul Josephs
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsApr 21, 2026 · In 1 weekQ1 2026
Financials
Lifecore Biomedical, Inc. FAQ
Common questions about Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. is scheduled to report earnings for Q1 2026 on April 21, 2026. Analysts estimate revenue of $26.6M.
Lifecore Biomedical, Inc. has approximately 459 employees.